General Information of the Compound
Compound ID |
CP0016282
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
509093-47-4
CHEMBL379787
CTK8E9833
DTXSID50475143
GTPL5990
HMS3229G05
HMS3263A20
IRAK-1-4 Inhibitor I
IRAK-1-4InhibitorI
IRAK-1/4 Inhibitor
IRAK-1/4 Inhibitor I
IRAK-1/4 inhibitor
IRAK1/4 Inhibitor I
Interleukin-1 Receptor-Associated-Kinase-1/4 Inhibitor
MLS006010636
MolPort-028-617-757
N-(2-Morpholinylethyl)-2-(3-nitrobenzoylamido)-benzimidazole
N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide
N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitrobenzamide
QTCFYQHZJIIHBS-UHFFFAOYSA-N
SCHEMBL3600534
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H21N5O4
|
||||||||||||||||||
Molecular Weight |
395.419
|
||||||||||||||||||
Canonical SMILES |
[O-][N+](=O)c1cccc(c1)C(=O)Nc1nc2ccccc2n1CCN1CCOCC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26)
Show/Hide
|
||||||||||||||||||
InChIKey |
QTCFYQHZJIIHBS-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound